Extranodal Marginal Zone B-cell Lymphoma
3 clinical trials · Condition
◉ Watch Extranodal Marginal Zone B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy (NCT06503276) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2023-11-01 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies (NCT01523223) | Robert Lowsky | 2012-01-01 |
| Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma (NCT00288067) | National Cancer Institute (NCI) | 2005-10-01 |
Track Extranodal Marginal Zone B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.